Table 2 Variables associated with treatment response of IMN in the univariable’ and multivariable’ analyses

Gender

2.009(0.876,4.608)

0.099

Age

0.996(0.976,1.027)

0.805

Weight

1.030(1.003,1.058)

0.028

1.035(1.000,1.072)

0.051

Course ≥ 6

0.370(0.168,0.818)

0.014

0.225(0.081,0.628)

0.004

History of hypertension

1.796(0.734,4.396)

0.200

URBC

1.026(1.004,1.048)

0.019

1.031(1.000,1.063)

0.053

UWBC

1.011(0.979,1.045)

0.494

UTP

1.172(1.083,1.268)

<0.001

1.140(1.029,1.262)

0.012

HGB

1.014(0.992,1.037)

0.213

ALB

0.937(0.871,1.008)

0.083

BUN

1.205(0.917,1.583)

0.182

Scr

1.008(0.989,1.027)

0.414

UA

1.002(0.998,1.006)

0.227

CysC

1.376(0.328,5.773)

0.662

eGFR

1.004(0.989,1.019)

0.628

TG

1.209(1.017,1.438)

0.031

1.001(0.778,1.242)

0.886

TCHO

0.951(0.810,1.117)

0.543

D-dimer

1.001(1.000,1.002)

0.006

1.001(1.000,1.002)

0.009

sPLA2R-Ab

1.005(1.002,1.009)

0.002

1.005(1.001,1.008)

0.006

RAAS inhibitors

0.515(0.229,1.158)

0.108

Immunosuppressant therapy

0.774(0.347,1.726)

0.532

CD20 monoclonal antibody

0.455(0.028,7.452)

0.581